Stocksigma LogoStocksigma Logo

Suven Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 120 (+30.4% YoY | -66.4% QoQ) ■ EBITDA: -11,092 (-39.0% YoY | +16.3% QoQ) ■ EBITDA Margin (%): -9,254 (-57553 bps YoY | -553791 bps QoQ) ■ PAT

Suven Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Suven Life Sciences Ltd · Outcome · 05 Nov 2026, 6:59 pm

Suven Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 120 (+30.4% YoY | -66.4% QoQ) ■ EBITDA: -11,092 (-39.0% YoY | +16.3% QoQ) ■ EBITDA Margin (%): -9,254 (-57553 bps YoY | -553791 bps QoQ) ■ PAT: -10,694 (-38.3% YoY | +16.2% QoQ) ■ EPS (INR): -3.77 (-8.3% YoY | +22.1% QoQ)

Original exchange filing (PDF)

More announcements from Suven Life Sciences Ltd

All Suven Life Sciences Ltd announcements